Bionime Corporation(TW:4737)
NT$55.70+0.20 (+0.36%)
TW:4737
Bionime Corporation financials statements
NT$55.70
At close:+0.20 (+0.36%)
Bionime Corporation (4737) Income Statement
Bionime Corporation Income Statement
Last quarter (Q2 2026), Bionime Corporation's total revenue was NT$426.63M, a decrease of 9.55% from the same quarter last year. In Q2, Bionime Corporation's net income was NT$-53.44M. See Bionime Corporation’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 1.84B | NT$ 1.93B | NT$ 1.76B | NT$ 2.21B | NT$ 1.85B | |
| NT$ 627.81M | NT$ 768.38M | NT$ 715.65M | NT$ 1.00B | NT$ 783.13M | |
| NT$ 825.17M | NT$ 897.43M | NT$ 715.65M | NT$ 843.12M | NT$ 728.40M | |
| Depreciation and Amortization | NT$ 182.28M | NT$ 182.81M | NT$ 163.42M | NT$ 153.23M | NT$ 154.66M |
| NT$ -15.08M | NT$ 59.28M | NT$ 179.78M | NT$ 270.36M | NT$ 248.29M | |
| NT$ -197.36M | NT$ -129.05M | NT$ -13.34M | NT$ 146.72M | NT$ 73.07M | |
| NT$ -52.05M | NT$ -56.66M | NT$ -18.54M | NT$ -44.93M | NT$ -709.00K | |
| NT$ -249.41M | NT$ -185.71M | NT$ -31.88M | NT$ 86.48M | NT$ 74.58M | |
| NT$ -180.28M | NT$ -127.22M | NT$ 6.21M | NT$ 91.03M | NT$ 87.41M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -2.65 | NT$ -1.91 | NT$ 0.09 | NT$ 1.36 | NT$ 1.33 |
| Diluted EPS | NT$ -2.65 | NT$ -1.91 | NT$ 0.09 | NT$ 1.35 | NT$ 1.31 |
| Weighted Average Shares Outstanding | 67.92M | 67.00M | 67.32M | 66.53M | 66.03M |
| Weighted Average Shares Outstanding (Diluted) | 67.92M | 67.00M | 67.32M | 67.50M | 66.85M |
Currency in TWD

